CRP and coronary artery disorder: Our study yielded analogous findings, indicating that in patients with established CAD, even 100% of them received statins therapy, elevated Lp(a) only had significant prognostic value for cardiovascular event risk in those with hs‐CRP levels > 2 mg/L.